Viewing Study NCT07310069


Ignite Creation Date: 2026-03-26 @ 3:17 PM
Ignite Modification Date: 2026-03-31 @ 11:03 AM
Study NCT ID: NCT07310069
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-12-30
First Post: 2025-12-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder Cancer
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module